Ryan, Bríd M <br/><br/>
Germline variation in NCF4, an innate immunity gene, is associated with an increased risk of colorectal cancer.  [electronic resource] 

 -  International journal of cancer  Mar 2014 
 - 1399-407 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.28457  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoma--etiology<br/>Aged<br/>Apoptosis<br/>Biomarkers, Tumor--genetics<br/>Blotting, Western<br/>Case-Control Studies<br/>Cell Adhesion<br/>Cell Cycle<br/>Cell Differentiation<br/>Cell Movement<br/>Cell Proliferation<br/>Colorectal Neoplasms--etiology<br/>Early Detection of Cancer<br/>Female<br/>Follow-Up Studies<br/>Genotype<br/>Germ-Line Mutation--genetics<br/>Humans<br/>Immunity, Innate--genetics<br/>Male<br/>Middle Aged<br/>NADP--metabolism<br/>NADPH Oxidases--genetics<br/>Neoplasm Staging<br/>Polymorphism, Single Nucleotide--genetics<br/>Prognosis<br/>RNA, Messenger--genetics<br/>Real-Time Polymerase Chain Reaction<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Risk Factors